Pharmacyclics, Inc. (PCYC) Posts Q3 non-GAAP Loss of 18c/Sh

Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q3 non-GAAP loss of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $37 thousand versus the consensus estimate of $2.41 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c